Authors: COHEN ML BLOOMQUIST W CALLIGARO D SWANSON S

Citation: Ml. Cohen et al., COMPARATIVE 5-HT4 RECEPTOR ANTAGONIST ACTIVITY OF LY353433 AND ITS ACTIVE HYDROXYLATED METABOLITES, Drug development research, 43(4), 1998, pp. 193-199

Authors: DELAPP N WU S BELAGAJE R JOHNSTONE E LITTLE S SHANNON H BYMASTER F CALLIGARO D MITCH C WHITESITT C WARD J SHEARDOWN M FINKJENSEN A JEPPESEN L THOMSEN C SAUERBERG P

Citation: N. Delapp et al., EFFECTS OF THE M1 AGONIST XANOMELINE ON PROCESSING OF HUMAN BETA-AMYLOID PRECURSOR PROTEIN (FAD, SWEDISH MUTANT) TRANSFECTED INTO CHINESE-HAMSTER OVARY-M1 CELLS, Biochemical and biophysical research communications, 244(1), 1998, pp. 156-160

Authors: BYMASTER F CARTER P SHANNON H DELAPP N WHITESITT C WARD J CALLIGARO D MITCH C SHEARDOWN M SWEDBERG M RIMVALL K FINKJENSEN A JEPPESEN L SAUERBERG P

Citation: F. Bymaster et al., STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO BY XANOMELINE AND OTHER MUSCARINIC AGENTS, Life sciences, 60(13-14), 1997, pp. 5-5

Authors: SHANNON HE WOMER DE DELAPP NW BYMASTER FP MITCH CH WARD JS WHITESITT C CALLIGARO D SWEDBERG MDB SHEARDOWN MJ SAUERBERG P RIMVALL K FINKJENSEN A JEPPESEN L

Citation: He. Shannon et al., MUSCARINIC AGONISTS PRODUCE ANALGESIA THROUGH PERTUSSIS-TOXIN-SENSITIVE MUSCARINIC RECEPTORS IN THE SPINAL-CORD, Life sciences, 60(13-14), 1997, pp. 78-78

Authors: MITCH C BROWN T BYMASTER F CALLIGARO D DIECKMAN D MERRITT L PETERS S QUIMBY S SHANNON N SHIPLEY L WARD J HANSEN K OLESEN P SAUERBERT P SHEARDOWN M SWEDBERG M GREENWOOD B

Citation: C. Mitch et al., MUSCARINIC ANTINOCICEPTIVE AGENTS WITH POTENT AND SELECTIVE EFFECTS ON THE GI TRACT - POTENTIAL APPLICATION FOR THE TREATMENT OF IRRITABLE-BOWEL-SYNDROME, Life sciences, 60(13-14), 1997, pp. 79-79

Authors: BRADY MT MCGRATH N BROUWERS P GELBER R FOWLER MG YOGEV R HUTTON N BRYSON YJ MITCHELL CD FIKRIG S BORKOWSKY W JIMENEZ E MCSHERRY G RUBINSTEIN A WILFERT CM MCINTOSH K ELKINS MM WEINTRUB PS BERNSTEIN L SHLIOZBERG J LIVINGSTON RA VINK P FLAUTT L KLINE MW RAYBORN T KAUL A LAWRENCE R CHANDWANI S RUBINHALE A KNOXBURKE K ALATTAR I COOPER ER PELTON SI REGAN AM DAMON B YOUNG B NOZYCE M CIHAK P WIZNIA A CHADWICK EG SILIO M KLAUKE BJ OLESKE JM COLABELLI NB CONNOR EM GERSHON A PITT J SHEA K CLARK P CERVIA JS EDELSON PJ SANDERSLAUFER D HINDS GA RAKUSAN TA SEVER J HERZOG K ELLAURIE M MCKINNEY RE LANE BA SANTACROCE S NESHEIM SR SAWYER M SARVER J MEADOWS L ABRAMS E KANEM N FRERE M URBANO R RAGNI MV MILLER B CARFAGNA E MENDEZ H HANDLESMAN E DIFILIPPO G BERGIN HF SHAH K RAO S VILLARICA NC CLINTRON AA HODES D BARZELAI A BUTLER L HEATON S GUPTA A AHERN L MUNOZ J LI K BAMJI M KENNEDY G DUMMITT M PAHWA S BAKSJI S HUNKLER JA CALLAWAY CC CRIM LB DIAZ C RIVERA C FLORES L BEAUCHAMP B DIAZ L AGUAYO R GARCIATRIAS DE FRENKEL LD GAUR S SCUDDER RC KECHULA IM LISCHNER HW GREGONIS SW TRESTON CS RAPHAEL SA CARRER MT PEREZ L BERRIOS Z BURCHETT SK MELVIN AJ COREY L MOHAN KM GRIECO M MCKINLEY G RIVERA J MOALLEN H SCHULLER G PRAMBERG JC ALCHEDIAK T VANDYKE RB CALLIGARO D CHURCH J DEVEIKIS A GILETTE S SPECTOR SA DANKNER WM INSTONE S STANGLE L WARA DW PETRU A WILLIAMSHERMAN D BAKER RC SIEGEL R MCOWEN N ROBINSON J WELLS L JOHNSON GM RICH KC HAYANI K TURPIN D SULLIVAN JL LUZURIAGA K STECHENBERG BW ROBINSON JE LIM W DUDEK V MUNDORF L SANTUCCI S FRENKEL L LAMBERT JS MURANTE B SCOTT GB GOURLEY J MENDOZA C DOYLE M CANTINI M

Citation: Mt. Brady et al., RANDOMIZED STUDY OF THE TOLERANCE AND EFFICACY OF HIGH-DOSE VERSUS LOW-DOSE ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH MILD-TO-MODERATE SYMPTOMS (AIDS CLINICAL-TRIALS GROUP 128), The Journal of infectious diseases, 173(5), 1996, pp. 1097-1106